Hello, Fool! | Login | Signup | My Fool
Dec 2, 2008 2:26 AM ET | Feedback | Site Changes | Help
A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.
View All Commentary (MRX)
Recs
comet9 (22.45) Submitted: 7/13/08 6:37 PM : Start Price: $18.72 MRX Score: -6.09
Slowed growth in earnings due to increased expenses with LipoSonix acquisition. Whether that business takes off or not, there is very good value here.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK